Glucocorticoid therapies are used widely in arrange of medical conditions including respiratory, allergic, inflammatory and autoimmune diseases. All forms of glucocorticoid delivery, even at therapeutic doses, have the potential to cause Cushing’s syndrome. Here, we present a case of exogenous Cushing’s syndrome resulting from recurrent use of intermittent high dose oral prednisone to treat asthma exacerbation.

First line anti-tubercular drugs are known to cause various adverse drug reactions including cutaneous reactions. We report a rare case of anti-tubercular treatment (ATT) induced lichenoid skin reaction in a 58 years old female with no prior history of rashes. She was put on fixed dose combination (FDC) tablets of first line anti-tuberculosis drugs and developed reaction one month after initiation of therapy.